Technology
Chemomab and Scipher Merge: A New Era for AI in Biotech Drug Development
Chemomab and Scipher Medicine's merger signals a strategic shift towards AI in drug development, with potential risks and rewards for investors.
Diana Kowalski • July 8, 2026
Analysis
Dream Finders Homes Goes Public with Hostile Bid for Beazer Homes: A Turning Point in M&A
Dream Finders Homes escalates its takeover bid for Beazer Homes, signaling a shift in M&A dynamics amid a challenging ho…
Marcus Rivera • Jul 8
Earnings
Eos Energy Enterprises Soars in Premarket: Analyzing the Frontier Power Partnership
Eos Energy Enterprises shares climbed 6.7% in premarket trading after announcing a partnership with Frontier Power USA, …
Sarah Chen • Jul 8
Markets
US Stock Futures Plummet Amid Geopolitical Tensions: Impact on Energy and Markets
US stock futures dive following Trump's declaration on Iran, sparking oil price surges and market turmoil.
James McAllister • Jul 8
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Analysis
Railroad Merger Responses: Union Pacific and Norfolk Southern's Next Moves
Marcus Rivera • Jul 7, 2026
Technology
Envirotech Vehicles' Bold Shift: From Electric Vehicles to AI Infrastructure
Sarah Chen • Jul 7, 2026
Markets
SpaceX's Nasdaq 100 Entry and Market Rally: What Traders Need to Know
James McAllister • Jul 7, 2026
IPO
General Fusion Set to Become First Publicly Traded Fusion Company: What Investors Should Know
Catherine Walsh • Jul 7, 2026
Technology
Autodesk's Acquisition of MaintainX: Implications for Stakeholders
Tyler Brooks • Jul 7, 2026
Economy
Solstice's Stock Volatility: Analyzing the Market Reaction to ESI Acquisition
Diana Kowalski • Jul 7, 2026